Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03597295
What this trial is testing

INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202)

Who this might be right for
Squamous Cell Carcinoma of Anal Canal
Incyte Corporation 94
Large-scale testing (Phase 3)Not Yet RecruitingNCT07540390
What this trial is testing

GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 442
Testing effectiveness (Phase 2)UnknownNCT05576961
What this trial is testing

Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

Who this might be right for
Solid TumorImmune Checkpoint InhibitorIntestinal Flora
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06577194
What this trial is testing

Neoadjuvant Short-Course Radiotherapy Followed by CAPOX Plus PD-1 Antibody and IL-2 in Locally Advanced Rectal Cancer (PRIDE01)

Who this might be right for
Rectal CancerAdvanced Solid Tumor
The First Affiliated Hospital with Nanjing Medical University 35
Testing effectiveness (Phase 2)Looking for participantsNCT06170710
What this trial is testing

Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 173
Testing effectiveness (Phase 2)Study completedNCT05235542
What this trial is testing

A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Akeso 128
Testing effectiveness (Phase 2)Study completedNCT04521348
What this trial is testing

Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid Cancer

Who this might be right for
Thyroid Cancer
Fudan University 103
Large-scale testing (Phase 3)Looking for participantsNCT05593458
What this trial is testing

Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1

Who this might be right for
Locally Advanced Gastric Carcinoma
Zhejiang University 190
Large-scale testing (Phase 3)Active Not RecruitingNCT05609968
What this trial is testing

Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 614
Not applicableUnknownNCT06124729
What this trial is testing

Evaluation of the Efficacy and Safety of Bevacizumab Combined With PD-1 Monoclonal Antibody in Preoperative Neoadjuvant Therapy for MSS Colorectal Cancer With Liver Metastases

Who this might be right for
Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 50
Testing effectiveness (Phase 2)UnknownNCT04239443
What this trial is testing

Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer

Who this might be right for
Advanced Non Small Cell Lung CancerUterine CancerSoft Tissue Sarcoma
Hunan Cancer Hospital 120
Early research (Phase 1)Active Not RecruitingNCT05878691
What this trial is testing

GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Advanced Solid TumorLymphoma
Glenmark Specialty S.A. 320
Testing effectiveness (Phase 2)WithdrawnNCT07038915
What this trial is testing

STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1

Who this might be right for
Lung Squamous Cell CarcinomaAnti-PD1/PDL1 Antibody
M.D. Anderson Cancer Center
Early research (Phase 1)Not Yet RecruitingNCT06934616
What this trial is testing

A Phase I, First-in-Human Study of GB268 (PD-1/CTLA-4/VEGF Trispecific Antibody) in Advanced Solid Tumors

Who this might be right for
Solid Tumor Cancer
Genor Biopharma Co., Ltd. 330
Testing effectiveness (Phase 2)UnknownNCT04926532
What this trial is testing

Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 30
Not applicableUnknownNCT06832228
What this trial is testing

Study of Pomalidomide Combination with Rituximab and Anti-PD-1 Antibody （PPR） in Third or Later Line Therapy of DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)
Zhejiang Cancer Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05540275
What this trial is testing

Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Henan Provincial People's Hospital 30
Testing effectiveness (Phase 2)Temporarily pausedNCT06728657
What this trial is testing

Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma

Who this might be right for
Stomach AdenocarcinomaGastro-esophageal Junction Cancer
Fudan University 68
Testing effectiveness (Phase 2)UnknownNCT03623581
What this trial is testing

Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226)

Who this might be right for
Alveolar Soft Part Sarcoma
Genor Biopharma Co., Ltd. 35
Large-scale testing (Phase 3)Not Yet RecruitingNCT07729956
What this trial is testing

BL-B01D1 Plus an Anti-PD-1 Antibody Versus Nab-paclitaxel Plus an Anti-PD-1 Antibody in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Express PD-L1 (PANKU-Breast04)

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Sichuan Baili Pharmaceutical Co., Ltd. 436
Next Page